AMG386 plus PLD
20060517
Phase 3 small_molecule terminated
Quick answer
AMG386 plus PLD for Fallopian Tube Cancer is a Phase 3 program (small_molecule) at Amgen with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Amgen
- Indication
- Fallopian Tube Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated